Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation
- PMID: 2507296
- DOI: 10.1210/endo-125-5-2710
Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation
Abstract
The effect of protracted GH-releasing factor (GRF) stimulation on adenohypophysial morphology was investigated in six mice transgenic for human GRF (hGRF). All animals had significantly higher plasma levels of GH and GRF and greater body weights than controls. Eight-month-old mice were killed, and the markedly enlarged pituitaries were studied by histology, immunocytochemistry, electron microscopy, and immunogold method, using double labeling at ultrastructural level. In all pituitaries, a massive hyperplasia, chiefly of mammosomatotrophs, was found. These bihormonal cells, containing GH and PRL, were demonstrated by light microscopy and ultrastructural immunocytochemistry. Electron microscopy revealed the presence of cells with characteristics of GH cells in three pituitaries and cells resembling human adenomatous mammosomatotrophs in the other three glands. All of these cells, regardless of their ultrastructural features, contained secretory granules heavily labeled for GH by immunogold technique; PRL labeling varied from cell to cell, with the predominance of a weak immunostaining and was colocalized with GH in secretory granules. These results indicate that chronic exposure to GRF excess leads to mammosomatotroph hyperplasia. It is suggested that GH cells proliferate and transform to mammosomatotrophs in response to GRF stimulation. Focal PRL cell hyperplasia noted in three pituitaries could also be due to a GRF effect. Longer exposure to GRF is needed to clarify whether GRF can cause adenoma.
Similar articles
-
Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.Endocrinology. 1992 Nov;131(5):2083-9. doi: 10.1210/endo.131.5.1425411. Endocrinology. 1992. PMID: 1425411
-
Colocalization of prolactin and growth hormone within specific adenohypophyseal cells in male, female, and lactating female rats.Endocrinology. 1987 Aug;121(2):625-30. doi: 10.1210/endo-121-2-625. Endocrinology. 1987. PMID: 3595534
-
An immunocytochemical and ultrastructural study of adenohypophyses of mice transgenic for human growth hormone.Endocrinology. 1990 Jan;126(1):608-15. doi: 10.1210/endo-126-1-608. Endocrinology. 1990. PMID: 2104591
-
Pituitary morphology of transgenic mice expressing bovine growth hormone.Lab Invest. 1993 May;68(5):584-91. Lab Invest. 1993. PMID: 8388524
-
The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.Endocrinology. 2001 Sep;142(9):3764-73. doi: 10.1210/endo.142.9.8382. Endocrinology. 2001. PMID: 11517152
Cited by
-
Mitotic Counts in Rat Adenohypophysial Thyrotrophs and Somatotrophs: Effects of Short-Term Thyroidectomy, Thyroxine, and Thyrotropin-Releasing Hormone.Endocr Pathol. 1999 Winter;10(4):335-341. doi: 10.1007/BF02739776. Endocr Pathol. 1999. PMID: 12114770
-
Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients.Pituitary. 2007;10(3):237-49. doi: 10.1007/s11102-007-0045-7. Pituitary. 2007. PMID: 17541749 Free PMC article.
-
The Pituitary in Gigantism.Endocr Pathol. 1995 Autumn;6(3):173-187. doi: 10.1007/BF02739881. Endocr Pathol. 1995. PMID: 12114738
-
Molecular basis of pituitary oncogenesis.J Neurooncol. 1999;45(1):83-96. doi: 10.1023/a:1006390306336. J Neurooncol. 1999. PMID: 10728913 Review.
-
X-linked acrogigantism syndrome: clinical profile and therapeutic responses.Endocr Relat Cancer. 2015 Jun;22(3):353-67. doi: 10.1530/ERC-15-0038. Epub 2015 Feb 24. Endocr Relat Cancer. 2015. PMID: 25712922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases